CXCL12 and pancreatic neoplasm: CAFs increase the expression of PD-L1 in pancreatic cancer by secreting CXCL5 and CXCL12 via phosphatidylinositol-3-kinase/protein kinase B signaling pathway, thus promoting the formation of immunosuppressive microenvironment (43, 44).